Also known as: Cft7455, 2504235-67-8, D86mf5h9wj, Cft-7455, (3s)-3-(6-((4-(morpholin-4-ylmethyl)phenyl)methyl)-2-oxobenzo(cd)indol-1-yl)piperidine-2,6-dione, 2,6-piperidinedione, 3-(6-((4-(4-morpholinylmethyl)phenyl)methyl)-2-oxobenz(cd)indol-1(2h)-yl)-, (3s)-

Molecular Formula

C₂₈H₂₇N₃O₄

Molecular Weight

469.5 g/mol

InChI Key

MUKCJOOKCZSQNW-DEOSSOPVSA-N

FDA UNII

D86MF5H9WJ

CEMSIDOMIDE is a small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications.

1 2D Structure

2D Structure

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(3S)-3-[6-[[4-(morpholin-4-ylmethyl)phenyl]methyl]-2-oxobenzo[cd]indol-1-yl]piperidine-2,6-dione

2.1.2 InChI

InChI=1S/C28H27N3O4/c32-25-11-10-24(27(33)29-25)31-23-9-8-20(21-2-1-3-22(26(21)23)28(31)34)16-18-4-6-19(7-5-18)17-30-12-14-35-15-13-30/h1-9,24H,10-17H2,(H,29,32,33)/t24-/m0/s1

2.1.3 InChI Key

MUKCJOOKCZSQNW-DEOSSOPVSA-N

2.2 Other Identifiers

2.2.1 UNII

D86MF5H9WJ

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Cft7455

2. 2504235-67-8

3. D86mf5h9wj

4. Cft-7455

5. (3s)-3-(6-((4-(morpholin-4-ylmethyl)phenyl)methyl)-2-oxobenzo(cd)indol-1-yl)piperidine-2,6-dione

6. 2,6-piperidinedione, 3-(6-((4-(4-morpholinylmethyl)phenyl)methyl)-2-oxobenz(cd)indol-1(2h)-yl)-, (3s)-

7. (3s)-3-[6-[[4-(morpholin-4-ylmethyl)phenyl]methyl]-2-oxobenzo[cd]indol-1-yl]piperidine-2,6-dione

8. 2,6-piperidinedione, 3-[6-[[4-(4-morpholinylmethyl)phenyl]methyl]-2-oxobenz[cd]indol-1(2h)-yl]-, (3s)-

9. Refchem:1081326

10. (s)-3-(6-(4-(morpholinomethyl)benzyl)-2-oxobenzo[cd]indol-1(2h)-yl)piperidine-2,6-dione

11. Unii-d86mf5h9wj

12. Cemsidomida

13. Cemsidomide [inn]

14. Cft7455; Cemsidomide

15. Cemisidomide (usan/inn)

16. Cemsidomide [usan]

17. Cft 7455

18. Orb1301216

19. Chembl5095227

20. Schembl22549709

21. Schembl29881140

22. Gtpl11961

23. Glxc-26095

24. (s)-cft7455

25. Ex-a6043

26. Nsc840579

27. Akos040758857

28. At41376

29. Nsc-840579

30. Bp-28982

31. Da-51799

32. Ms-28680

33. Hy-144841

34. Cs-0435593

35. D12933

36. En300-43393872

37. F987600

38. (3s)-3-(6-{[4-(morpholin-4-ylmethyl)phenyl]methyl}-2-oxobenz[cd]indol-1(2h)-yl]piperidine-2,6-dione

39. (3s)-3-[6-[[4-(4-morpholinylmethyl)phenyl]methyl]-2-oxobenz[cd]indol-1(2h)-yl]-2,6-piperidinedione

40. (3s)-3-[6-[[4-(morpholinomethyl)phenyl]methyl]-2-oxo-benzo[cd]indol-1-yl]piperidine-2,6-dione

41. (3s)-3-[9-({4-[(morpholin-4-yl)methyl]phenyl}methyl)-3-oxo-2-azatricyclo[6.3.1.0,4,12]dodeca-1(12),4,6,8,10-pentaen-2-yl]piperidine-2,6-dione

2.4 Create Date

2020-12-19

3 Chemical and Physical Properties

Molecular Formula	C₂₈H₂₇N₃O₄
Molecular Weight	469.5 g/mol
XLogP3	2.9
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	5
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	79
Heavy Atom Count	35
Formal Charge	0
Complexity	819
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

Cemsidomide

Cemsidomide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

DEVELOPMENTS

7 Drugs in Development

Filters